CLARITIN LIQUID CAPSULES 10 MG
LORATADINE : 10 MG · DIN 02404494 · BAYER INC
Health Canada status: MARKETED
What is CLARITIN LIQUID CAPSULES?
CLARITIN LIQUID CAPSULES 10 MG contains LORATADINE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02404494, held by BAYER INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 31-May-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CLARITIN LIQUID CAPSULES used for?
Relief of symptoms associated with seasonal and perennial allergic rhinitis (sneezing, nasal discharge, itching) and chronic urticaria/allergic dermatologic disorders.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02404494 |
|---|---|
| Brand name | CLARITIN LIQUID CAPSULES |
| Generic / active ingredient | LORATADINE : 10 MG |
| Manufacturer | BAYER INC |
| Strength | 10 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R06AX13 LORATADINE |
| AHFS class | 04:08.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-May-2016 |
| Original market date | 2013-07-01 00:00:00 |
How is it administered?
Adults and Children 12 years and over: One 10 mg capsule once daily. Patients with severe liver impairment: 10 mg every other day.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at room temperature 15° to 30°C. Protect from exposure to excessive moisture. Keep out of reach of children.
How is it supplied?
Available in blisters of 24 and 40 packaged in a carton.
Contraindications
Hypersensitivity to loratadine, descarboethoxy-loratadine, or to any ingredient in the formulation or component of the container.
Warnings and precautions
Dosing adjustment required for severe liver disease. Use with caution in severe renal insufficiency. Not recommended for pregnant or lactating women.
What can be used instead?
Other Canadian products sharing ATC code R06AX13 LORATADINE. 11 of 20 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| 24 HOUR ALLERGY REMEDY | 10 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02280159 |
| ALLERGY REMEDY | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02375990 |
| ALLERTIN | 10 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02390388 |
| APO-LORATADINE | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02243880 |
| CLARITIN ALLERGY | 10 MG | TABLET | BAYER INC | MARKETED | DIN 00782696 |
| CLARITIN KIDS | 5 MG / 5 ML | SYRUP | BAYER INC | MARKETED | DIN 02241523 |
| CLARITIN KIDS RAPID DISSOLVE | 5 MG | TABLET (ORALLY DISINTEGRATING) | BAYER INC | MARKETED | DIN 02508761 |
| CLARITIN RAPID DISSOLVE | 10 MG | TABLET (ORALLY DISINTEGRATING) | BAYER INC | MARKETED | DIN 02237734 |
| LORATADINE | Strength | Tablet | APOTEX INC 150 Signet Drive Toronto Ontario Canada M9L 1T9 | MARKETED | DIN 02366444 |
| LORATADINE SOFT GEL CAPSULES | Strength | Capsule | APOTEX INC 150 Signet Drive Toronto Ontario Canada M9L 1T9 | MARKETED | DIN 02379481 |
Who else supplies LORATADINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. LORATADINE appears in 1512 registered pack listings across 11 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.